Chemotherapy Combined With Immunotherapy as a First-Line Treatment Brings Benefits to Patients With Lung Squamous Cell Carcinoma but Different Risks of Adverse Reactions: A Systematic Review and Meta-Analysis

Objective To explore the efficacy and safety of chemotherapy combined with immunotherapy as the first-line treatment of advanced or metastatic squamous NSCLC. Methods Two researchers independently searched PubMed, the Cochrane Library, EMBASE, CNKI, Wanfang Data, and other databases by using a compu...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Qian, Zhang, Zhen, Li, Xiaoli, Bu, Lingbiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283920/
https://www.ncbi.nlm.nih.gov/pubmed/35847044
http://dx.doi.org/10.3389/fphar.2022.940567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283920/
https://www.ncbi.nlm.nih.gov/pubmed/35847044
http://dx.doi.org/10.3389/fphar.2022.940567

Ejemplares similares